110 related articles for article (PubMed ID: 12407018)
1. Characterization of mac25/angiomodulin expression by high endothelial venule cells in lymphoid tissues and its identification as an inducible marker for activated endothelial cells.
Usui T; Murai T; Tanaka T; Yamaguchi K; Nagakubo D; Lee CM; Kiyomi M; Tamura S; Matsuzawa Y; Miyasaka M
Int Immunol; 2002 Nov; 14(11):1273-82. PubMed ID: 12407018
[TBL] [Abstract][Full Text] [Related]
2. A high endothelial venule secretory protein, mac25/angiomodulin, interacts with multiple high endothelial venule-associated molecules including chemokines.
Nagakubo D; Murai T; Tanaka T; Usui T; Matsumoto M; Sekiguchi K; Miyasaka M
J Immunol; 2003 Jul; 171(2):553-61. PubMed ID: 12847218
[TBL] [Abstract][Full Text] [Related]
3. Identification of cell-binding site of angiomodulin (AGM/TAF/Mac25) that interacts with heparan sulfates on cell surface.
Sato J; Hasegawa S; Akaogi K; Yasumitsu H; Yamada S; Sugahara K; Miyazaki K
J Cell Biochem; 1999 Nov; 75(2):187-95. PubMed ID: 10502291
[TBL] [Abstract][Full Text] [Related]
4. Angiomodulin, a marker of cancer vasculature, is upregulated by vascular endothelial growth factor and increases vascular permeability as a ligand of integrin αvβ3.
Komiya E; Sato H; Watanabe N; Ise M; Higashi S; Miyagi Y; Miyazaki K
Cancer Med; 2014 Jun; 3(3):537-49. PubMed ID: 24737780
[TBL] [Abstract][Full Text] [Related]
5. Angiomodulin (IGFBP7) is a cerebral specific angiocrine factor, but is probably not a blood-brain barrier inducer.
Bar O; Gelb S; Atamny K; Anzi S; Ben-Zvi A
Fluids Barriers CNS; 2020 Apr; 17(1):27. PubMed ID: 32238174
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization.
Girard JP; Baekkevold ES; Yamanaka T; Haraldsen G; Brandtzaeg P; Amalric F
Am J Pathol; 1999 Dec; 155(6):2043-55. PubMed ID: 10595934
[TBL] [Abstract][Full Text] [Related]
7. Angiomodulin is a specific marker of vasculature and regulates vascular endothelial growth factor-A-dependent neoangiogenesis.
Hooper AT; Shmelkov SV; Gupta S; Milde T; Bambino K; Gillen K; Goetz M; Chavala S; Baljevic M; Murphy AJ; Valenzuela DM; Gale NW; Thurston G; Yancopoulos GD; Vahdat L; Evans T; Rafii S
Circ Res; 2009 Jul; 105(2):201-8. PubMed ID: 19542015
[TBL] [Abstract][Full Text] [Related]
8. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
[TBL] [Abstract][Full Text] [Related]
9. Constitutive lymphocyte transmigration across the basal lamina of high endothelial venules is regulated by the autotaxin/lysophosphatidic acid axis.
Bai Z; Cai L; Umemoto E; Takeda A; Tohya K; Komai Y; Veeraveedu PT; Hata E; Sugiura Y; Kubo A; Suematsu M; Hayasaka H; Okudaira S; Aoki J; Tanaka T; Albers HM; Ovaa H; Miyasaka M
J Immunol; 2013 Mar; 190(5):2036-48. PubMed ID: 23365076
[TBL] [Abstract][Full Text] [Related]
10. VCAM-1 is not involved in LPAM-1 (alpha 4 beta p/alpha 4 beta 7) mediated binding of lymphoma cells to high endothelial venules of mucosa-associated lymph nodes.
Hahne M; Lenter M; Jäger U; Isenmann S; Vestweber D
Eur J Cell Biol; 1993 Aug; 61(2):290-8. PubMed ID: 7693472
[TBL] [Abstract][Full Text] [Related]
11. Messenger ribonucleic acids for MAC25 and connective tissue growth factor (CTGF) are inversely regulated during folliculogenesis and early luteogenesis.
Wandji SA; Gadsby JE; Barber JA; Hammond JM
Endocrinology; 2000 Jul; 141(7):2648-57. PubMed ID: 10875270
[TBL] [Abstract][Full Text] [Related]
12. The requirement of both intracellular reactive oxygen species and intracellular calcium elevation for the induction of heparin-binding EGF-like growth factor in vascular endothelial cells and smooth muscle cells.
Kayanoki Y; Higashiyama S; Suzuki K; Asahi M; Kawata S; Matsuzawa Y; Taniguchi N
Biochem Biophys Res Commun; 1999 May; 259(1):50-5. PubMed ID: 10334914
[TBL] [Abstract][Full Text] [Related]
13. Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes.
Streeter PR; Rouse BT; Butcher EC
J Cell Biol; 1988 Nov; 107(5):1853-62. PubMed ID: 2460470
[TBL] [Abstract][Full Text] [Related]
14. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.
Yonekura H; Yamamoto Y; Sakurai S; Petrova RG; Abedin MJ; Li H; Yasui K; Takeuchi M; Makita Z; Takasawa S; Okamoto H; Watanabe T; Yamamoto H
Biochem J; 2003 Mar; 370(Pt 3):1097-109. PubMed ID: 12495433
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
16. Expression of angiomodulin (tumor-derived adhesion factor/mac25) in invading tumor cells correlates with poor prognosis in human colorectal cancer.
Adachi Y; Itoh F; Yamamoto H; Arimura Y; Kikkawa-Okabe Y; Miyazaki K; Carbone DP; Imai K
Int J Cancer; 2001 Jul; 95(4):216-22. PubMed ID: 11400113
[TBL] [Abstract][Full Text] [Related]
17. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional programs of lymphoid tissue capillary and high endothelium reveal control mechanisms for lymphocyte homing.
Lee M; Kiefel H; LaJevic MD; Macauley MS; Kawashima H; O'Hara E; Pan J; Paulson JC; Butcher EC
Nat Immunol; 2014 Oct; 15(10):982-95. PubMed ID: 25173345
[TBL] [Abstract][Full Text] [Related]
19. Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: reduction of vascular endothelial growth factor (VEGF).
Oliver SJ; Cheng TP; Banquerigo ML; Brahn E
Cell Immunol; 1995 Dec; 166(2):196-206. PubMed ID: 7497521
[TBL] [Abstract][Full Text] [Related]
20. Expression profile of active genes in mouse lymph node high endothelial cells.
Izawa D; Tanaka T; Saito K; Ogihara H; Usui T; Kawamoto S; Matsubara K; Okubo K; Miyasaka M
Int Immunol; 1999 Dec; 11(12):1989-98. PubMed ID: 10590265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
